Swine brucellosis is an infectious disease caused by the bacteria Brucella suis (B. suis). It produces chronic inflammatory lesions in the reproductive organs that lead to abortions, infertility, and birth of weak piglets. The disease can also attack joints, leading to lameness.
The United States eliminated the disease from commercial swine in 2011. However, swine brucellosis is still present in wild swine in this country. Any mammal exposed to feral swine are at risk of infection. And yes, Swine Brucellosis can also infect people.
During their research into an effective contraception for feral hogs, our Founders asked themselves if their research could also address the brucellosis problem. Nearly all of our ”research partners” (our pig family), showed signs of brucellosis, with many suffering greatly or succumbing to the disease completely. Because the oral vaccine is similar to the oral vaccines used for COVID-19 and other newer generation treatments, it was not a stretch to use the immunologic capability of this new design to attack brucellosis. This vaccine, if successful, will be able to be used across all wild and domestic animals as a preventive vaccine.
Check our FERAL HOG BRUCELLOSIS ORAL VACCINE PROJECT page to see the latest status.
Vaccine Testing and Data Collection – Using similar tools currently employed to design and create vaccines for the Flu and COVID, we will be tasked to refine and test this solution. This is a precise process with key controls and steps required for validation and approval by State and Federal Agencies. The testing and permitting process is expensive, and funds are needed to allow for contracting out the live animal testing and any resulting redesign and retesting as required by the reviewers. Development for commercial delivery and sales will most likely be best contracted out to third party laboratories that specialize in this area. We need help with your donations to develop, test, permit and prepare for commercial deployment.
Leave a Reply